Antinociceptive effects of fluoxetine and paroxetine with their related actions on glycemia in mice

Neuroendocrinology Letters

Volumn 27, Issue 1-2, 2006, Pages 281-287

  Kesim, Murar ^a   Duman, Erdem N ^a   Kadioglu, Mine ^a   Ulku, Cunay ^a   Muci, Efnan ^a   Kalyoncu, Nuri I ^a   Yaris, Ersin ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Antinociception; Blood glucose levels; Diabetes; Fluoxetine; Mice; Paroxetine; Streptozotocin

Indexed keywords

FLUOXETINE; GLUCOSE; PAROXETINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG MONITORING; EXPERIMENTAL DESIGN; FEMALE; GLUCOSE BLOOD LEVEL; HOT PLATE TEST; MALE; NONHUMAN; RANDOMIZATION; RAT; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 33745650472     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aley KO, Levine JD. Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain. 2001; 2(3):146-50.
2. Anjaneyulu M, Chopra K. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-incluced diabetic mice. Eur J Pharmacol. 2004; 497(3):285-92.
3. Bourin M, Chue P, Guillon Y. Paroxetine: A review. CNS Drug Rev. 2001; 7:25-47.
4. Coquoz D, Porchet HC, Dayer P. Central analgesic effects of desipramine, fluvoxamine and moclobemide after single oral dosing: a study in healthy volunteers. Clin Pharmacol Ther. 1993; 54: 339-344.
5. Courteix C, Bardin M, Massol J, Fialip J, Lavarenne J, Eschalier A. Daily insulin treatment relieves long-term hyperalgesia in streptozocin diabetic rats. Neuroreport. 1996; 7(12): 1922-4.
6. Deeg MA, Lipkin EW. Hypoglycemia associated with the use of fluoxetine. West J Med. 1996; 164(3): 262-3.
7. Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res. 2003; 960(1-2): 174-83.
8. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm. 2004; 61(2): 160-73.
9. Duman EN, Kesim M, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci. 2004; 94(2): 161-5.
10. Erenmemisoglu A, Ozdogan UK, Saraymen R, Tutus A. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J Pharm Pharmacol. 1999; 51(6): 741-3.
11. Feinmann C. Pain relief by antidepressants: possible modes of action. Pain. 1985; 23:1-8.
12. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Evidence based data from animal and human experimental studies on pain relief with antidepressants: A structured review. Pain Med. 2000; 1:310-316.
13. Gomez R, Huber J, Tombini G, Barros HM. Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats. Braz J Med Biol Res. 2001; 34(1): 57-64.
14. Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry. 1995; 56(4): 128-36.
15. Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull. 1997; 33(2):261-4.
16. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry. 2001; 13(l):31-41.
17. Gray AM, Spencer PS, Sewell RD. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol. 1998; 124(4):669-74.
18. Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med. 1997; 12: 384-389.
19. Kesim M, Duman EN, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. The different roles of 5-HT(2) and 5-HT(3) receptors on antinociceptive effect of paroxetine in chemical stimuli in mice. J Pharmacol Sci. 2005; 97(1): 61-6. Epub 2005 Jan 15.
20. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000; 23(5): 618-23.
21. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997; 59(3): 241-50.
22. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992; 326(19):1250-6.
23. Oswald P, Souery D, Mendlewicz J. Fluvoxamine-induced hyperglycaemia in a diabetic patient with comorbid depression. Int J Neuropsychopharmacol. 2003; 6(1):85-7.
24. Petty KJ. Hyperglycemia associated with paroxetine. Ann Intern Med. 1996; 125(9):782.
25. Pollak PT, Mukherjee SD, Fraser AD. Sertraline-induced hypoglycemia. Ann Pharmacother. 2001; 35(11): 1371-4.
26. Romanovsky D, Hastings SL, Stimers JR, Dobretsov M. Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes. J Peripher Nerv Syst. 2004; 9(2): 62-9.
27. Sansone RA, Sansone LA. Sertraline-induced hyperglycemia: case report. Int J Psychiatry Med. 2003; 33(1): 103-5.
28. Sawynok J, Esser MJ, Reid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain. 1999; 82(2): 149-58.
29. Singh VP, Jain NK, Kulkarni SK. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res. 2001;915:218-226.
30. Smith AJ. The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol. 1998; 12(4): 407-13.
31. Vinik Al, Vinik E. Prevention of the complications of diabetes. Am J Manag Care. 2003; 9(3 Suppl): S63-80.
32. Yamada J, Sugimoto Y, Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur J Pharmacol. 1999; 382(3): 211-5.